Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease-A Randomized, Controlled, Open-Label, Multicenter Study
Oliver Schröder(Krankenhaus Sachsenhausen), Jürgen M. Stein(Unknown), Ursula Seidler(Medizinische Hochschule Hannover), Andreas de Weerth(Agaplesion Frankfurter Diakonie Kliniken), Axel Dignaß(Goethe University Frankfurt), Stefan Schreiber(Christian-Albrechts-Universität zu Kiel), Hans Herfarth(University of North Carolina at Chapel Hill), Marc Schrott(Goethe University Frankfurt), Ulrich Junge(Klinikum Bielefeld), Max Reinshagen(Evangelisches Krankenhaus Göttingen-Weende), O Mickisch(University of Mannheim)
Cited by 234
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k